Madorra
PrivateLast Round
Grant
Sep 1, 2021
Total Funding Raised
$5.42M
Company Overview
Madorra is a medical device company that has developed a non-hormonal, non-invasive, home-use ultrasound device for treating moderate to severe vulvovaginal atrophy (VVA), a component of genitourinary syndrome of menopause (GSM). The company's solution is designed to provide a safe and effective alternative to hormone-based therapies, particularly for post-menopausal women and breast cancer survivors. The device uses therapeutic ultrasound to stimulate the body's natural lubricating mechanism. Spun out of the Stanford University Biodesign Fellowship Program, Madorra has received Breakthrough Device designation from the FDA and has conducted clinical trials to prove its efficacy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Madorra Comparables
Compare Madorra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AVeta Medical | 82% | |
| Joylux | 78% | |
| Axena Health | 66% |
Madorra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2021 | ||||
| Series A | Sep 4, 2018 | ||||
| Grant | Feb 1, 2018 | ||||
| Angel | Apr 27, 2017 |
Key People
Founding team and executive leadership
Madorra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OneVentures | Series A |
| StartX | Series A |
| U.S. Department of Health and Human Services | Grant |
| Astia Angels | Series A |
| Portfolia | Series A |
| Avestria Ventures | Series A |
| Berkeley Catalyst Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2021
Secured $1.5M from the U.S. Department of Health and Human Services.
- Sep 4, 2018
$2.88M round led by OneVentures.
Madorra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Madorra's valuation, stock price, and market status.
Is Madorra a public or private company?
Madorra is a private company.
What is the current stock price of Madorra?
Madorra is a private company with no public stock price. Caplight tracks Madorra's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Madorra worth (valuation)?
Valuation information for Madorra is not publicly available.
Can I buy Madorra stock?
Madorra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Madorra's last funding round?
Madorra's most recent funding round was Grant on September 1, 2021.
Who are the main investors in Madorra?
Key investors in Madorra include OneVentures.
Will Madorra IPO soon?
No public IPO plans have been announced for Madorra.
How can I track Madorra secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Madorra's secondary market activity and sign up for updates.